UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. The goal of the grants is for researchers to make significant strides toward the development of potential therapies within the next three years. If the strategies prove successful, they could then be further prepared as potential therapies and submitted as new drug applications to the U.S. Food and Drug Administration, leading toward clinical trials...
No comments:
Post a Comment